Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 28, 2011 | March 02, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 28, 2011 · Filed March 02, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 109,429 |
Ending reported balance
After 2011-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2011-02-28 · Tax withholding · Disposed 8,526 · Balance 110,993 Row 2 · 2011-02-28 · Sale · Disposed 100 · Balance 110,893 Row 3 · 2011-02-28 · Sale · Disposed 600 · Balance 110,293 Row 4 · 2011-02-28 · Sale · Disposed 864 · Balance 109,429 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 14,342 |
Reported balance
Holding disclosure · report date 2011-02-28 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 14,342 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2011. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2011.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2009 Filed Aug 26, 2009 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,324 | $45.39 | $105,486.36 |
DisclosureSEC source: 0001179110-09-012589 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,505 Read SEC document |
| August 24, 2009 Filed Aug 26, 2009 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,082 | $33.23 | $102,419.17 |
DisclosureSEC source: 0001179110-09-012589 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2009 Filed Sep 4, 2009 22:40 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,622 | $0.00 Strike: $45.39 | $0.00 |
DisclosureSEC source: 0001179110-09-012952 · edgar.xml · derivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,622 Underlying: Common shares · 2,622 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F1 · balance_after: Amended to report the withholding of 298 shares to satisfy the reporting person's tax obligation in connection with the exercise of stock options. The number of securities directly beneficially owned following this transaction, as shown in column 5 of Table I above, and the number of derivative securities beneficially owned following this transaction, as shown in column 9 of Table II above, now reflect this withholding. The corresponding numbers in column 5 of Table I of the reporting person's Form 4 filed on September 1, 2009 should be reduced to reflect this withholding, as well. Read SEC document |
| August 24, 2009 Filed Sep 4, 2009 22:40 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,622 | $45.39 | $119,012.58 |
DisclosureSEC source: 0001179110-09-012952 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,207 F1 · balance_after: Amended to report the withholding of 298 shares to satisfy the reporting person's tax obligation in connection with the exercise of stock options. The number of securities directly beneficially owned following this transaction, as shown in column 5 of Table I above, and the number of derivative securities beneficially owned following this transaction, as shown in column 9 of Table II above, now reflect this withholding. The corresponding numbers in column 5 of Table I of the reporting person's Form 4 filed on September 1, 2009 should be reduced to reflect this withholding, as well. Read SEC document |
| August 06, 2009 Filed Aug 7, 2009 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,600 | $43.81 | $113,908.60 |
DisclosureSEC source: 0001179110-09-011787 · edgar.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,747 Read SEC document |
| August 06, 2009 Filed Aug 7, 2009 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $43.81 | $39,429.09 |
DisclosureSEC source: 0001179110-09-011787 · edgar.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,347 Read SEC document |
| August 06, 2009 Filed Aug 7, 2009 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,500 | $43.81 | $503,815.00 |
DisclosureSEC source: 0001179110-09-011787 · edgar.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,247 Read SEC document |
| April 22, 2009 Filed Apr 23, 2009 21:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,801 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0001104659-09-025851 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,801 Underlying: Common Shares · 2,801 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 22, 2009 Filed Apr 23, 2009 21:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,279 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-09-025851 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,630 Underlying: Common Shares · 3,279 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 22, 2009 Filed Apr 23, 2009 21:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,801 | $44.37 | $124,280.37 |
DisclosureSEC source: 0001104659-09-025851 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,747 Read SEC document |
| April 22, 2009 Filed Apr 23, 2009 21:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,279 | $33.23 | $108,965.76 |
DisclosureSEC source: 0001104659-09-025851 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2009 Filed Apr 17, 2009 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,716 | $42.66 | $73,204.56 |
DisclosureSEC source: 0001104659-09-024852 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,269 Read SEC document |
| March 05, 2009 Filed Mar 9, 2009 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 3,549 | $0.00 Strike: $47.18 | $0.00 |
DisclosureSEC source: 0001104659-09-015578 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,549 Underlying: Common Shares · 3,549 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2009 Filed Mar 9, 2009 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,284 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-09-015578 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,909 Underlying: Common Shares · 4,284 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2009 Filed Mar 9, 2009 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,549 | $47.18 | $167,441.82 |
DisclosureSEC source: 0001104659-09-015578 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,985 Read SEC document |
| March 05, 2009 Filed Mar 9, 2009 21:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,284 | $33.23 | $142,363.32 |
DisclosureSEC source: 0001104659-09-015578 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2009 Filed Mar 4, 2009 00:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,976 | $50.58 | $201,106.08 |
DisclosureSEC source: 0001104659-09-013962 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,250 Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 38,700 | $0.00 Strike: $54.14 | $0.00 |
DisclosureSEC source: 0001104659-09-011806 · a4.xml · derivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,700 Underlying: Common Shares · 38,700 shares Expires 2019-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,900 on 02/20/2010, 12,900 on 02/20/2011, and 12,900 on 02/20/2012. Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 27,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-011806 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,226 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2009 Filed Feb 19, 2009 21:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 17 | $54.41 | $924.97 |
DisclosureSEC source: 0001104659-09-010777 · a4.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,026 Read SEC document |
| February 17, 2009 Filed Feb 19, 2009 21:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $54.41 | $21,764.80 |
DisclosureSEC source: 0001104659-09-010777 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,043 Read SEC document |
| February 17, 2009 Filed Feb 19, 2009 21:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,433 | $54.94 | $78,729.02 |
DisclosureSEC source: 0001104659-09-010777 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,443 Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 3,878 | $0.00 Strike: $55.57 | $0.00 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · derivative · entry 11 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,878 Underlying: Common Shares · 3,878 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 4,916 | $0.00 Strike: $55.57 | $0.00 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · derivative · entry 10 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,916 Underlying: Common Shares · 4,916 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 4,841 | $0.00 Strike: $55.57 | $0.00 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · derivative · entry 9 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,841 Underlying: Common Shares · 4,841 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,718 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · derivative · entry 8 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,838 Underlying: Common Shares · 4,718 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,870 | $0.00 Strike: $42.29 | $0.00 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · derivative · entry 7 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,870 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 5,618 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · derivative · entry 6 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,618 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 13,635 | $55.57 | $757,696.95 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,876 Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,718 | $41.03 | $193,587.56 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,870 | $42.29 | $248,248.76 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2009 Filed Feb 6, 2009 00:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,618 | $43.70 | $245,511.09 |
DisclosureSEC source: 0001104659-09-006937 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2009 Filed Feb 5, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,353 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-09-006480 · a4.xml · derivative · entry 8 Patton Donald V JR · CIK 0001396490 · Seinor Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,353 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 02, 2009 Filed Feb 5, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,003 | $0.00 Strike: $53.55 | $0.00 |
DisclosureSEC source: 0001104659-09-006480 · a4.xml · derivative · entry 7 Patton Donald V JR · CIK 0001396490 · Seinor Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,003 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 02, 2009 Filed Feb 5, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $55.35 | $22,140.00 |
DisclosureSEC source: 0001104659-09-006480 · a4.xml · nonDerivative · entry 5 Patton Donald V JR · CIK 0001396490 · Seinor Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,305 Read SEC document |
| February 02, 2009 Filed Feb 5, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,953 | $55.35 | $108,100.50 |
DisclosureSEC source: 0001104659-09-006480 · a4.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Seinor Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,705 Read SEC document |
| February 02, 2009 Filed Feb 5, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,003 | $55.50 | $111,166.50 |
DisclosureSEC source: 0001104659-09-006480 · a4.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Seinor Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,658 Read SEC document |
| February 02, 2009 Filed Feb 5, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,353 | $42.50 | $99,997.32 |
DisclosureSEC source: 0001104659-09-006480 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Seinor Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2009 Filed Feb 5, 2009 00:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,003 | $53.55 | $107,260.65 |
DisclosureSEC source: 0001104659-09-006480 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Seinor Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2008 Filed Oct 23, 2008 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,364 | $0.00 Strike: $57.55 | $0.00 |
DisclosureSEC source: 0001104659-08-065470 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,364 Underlying: Common Shares · 2,364 shares Expires 2011-02-08 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 21, 2008 Filed Oct 23, 2008 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,693 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-065470 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,287 Underlying: Common Shares · 2,693 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 21, 2008 Filed Oct 23, 2008 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,364 | $57.55 | $136,048.20 |
DisclosureSEC source: 0001104659-08-065470 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,305 Read SEC document |
| October 21, 2008 Filed Oct 23, 2008 21:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,693 | $45.45 | $122,393.62 |
DisclosureSEC source: 0001104659-08-065470 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2008 Filed Sep 8, 2008 21:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,902 | $0.00 Strike: $57.93 | $0.00 |
DisclosureSEC source: 0001104659-08-057539 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,902 Underlying: Common Shares · 2,902 shares Expires 2011-02-08 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 04, 2008 Filed Sep 8, 2008 21:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,317 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-057539 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,980 Underlying: Common Shares · 3,317 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 04, 2008 Filed Sep 8, 2008 21:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,902 | $57.93 | $168,112.86 |
DisclosureSEC source: 0001104659-08-057539 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,976 Read SEC document |
| September 04, 2008 Filed Sep 8, 2008 21:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,317 | $45.45 | $150,753.67 |
DisclosureSEC source: 0001104659-08-057539 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 7,431 | $0.00 Strike: $57.37 | $0.00 |
DisclosureSEC source: 0001104659-08-045349 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,431 Underlying: Common Shares · 7,431 shares Expires 2011-02-08 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 8,451 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-045349 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,297 Underlying: Common Shares · 8,451 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 7,431 | $57.37 | $426,316.47 |
DisclosureSEC source: 0001104659-08-045349 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,561 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.